Search results for: Biontech

From leaked emails and reports to Trial Site News in June 2022, it indicates that as early as November 10, 2020, the European regulatory agency (EMA) staff, who oversees the evaluation of medicinal products for the European Union, had reason to be concerned about the rushed speed of the regulatory process with respect to robustness of assessment, plus they were aware of potential issues with Pfizer-BioNTech's vaccine batch integrity. The emails reveal that regulatory bodies like the FDA, MHRA, EMA and Health Canada knew of the differences in batches, regarding % mRNA integrity and the presence of uncharacterised fragments of RNA in batches ("impurities"), making the ‘safety and efficacy’ of the COVID-19 vaccine an unknown and could account for the variation in adverse reactions to batch/lot numbers. Knowing these issues the regulators granted various designations of emergency use authorisation a few weeks to months later - which would not pass normal regulation.

On December 2, 2020, the Pfizer-BioNTech COVID-19 vaccine was "temporarily authorised", by UK's Medicines and Healthcare products Regulatory Agency ( MHRA), becoming the first COVID-19 vaccine to be authorised anywhere in the world, "paving the way for mass vaccination". [1, 2] The vaccine was reported to offer "up to 95% protection against Covid-19 illness".  Pfizer's CEO stated on December 3, 2020 that Pfizer don't know if the vaccine will prevent transmission - the entire purpose of a mass vaccination campaign. The governments authorisation "follows months of rigorous clinical trials and a thorough analysis of the data by experts at the MHRA who have concluded that the vaccine has met its strict standards of safety, quality and effectiveness", contradictory to Pfizer FOIA documents. On 30 December "the cheaper and easier-to-distribute Oxford-AstraZeneca  COVID-19 vaccine” was approved.  A third vaccine, produced by Moderna, was approved for use in the UK in January 2021. Finally, Janssen’s single-dose vaccine was approved in May 2021, although it is yet to be used. [1, 2]

On December 21, 2020 the European Medicines Agency (EMA) granted Conditional Marketing Authorization (CMA) for the Pfizer-BioNTech COVID-19 vaccine (Comirnaty) following European Medicines Agency (EMA) “positive opinion, to BNT162b2 for active immunisation of individuals aged 16 years and older to prevent COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” in people from 16 years of age. [1, 2] They stating that "EMA’s human medicines committee (CHMP) has completed its rigorous evaluation of Comirnaty" concluding by consensus that sufficiently robust data on the quality, safety and efficacy of the vaccine are now available to recommend a formal conditional marketing authorisation." In 2022, leaked emails would reveal that there was "concern over accelerated timelines to ensure they would meet the ‘deadline’ for vaccine authorization at the expense of a robust assessment", and there was great pressure placed on the EMA staff by the European Commissioner, Ursula von der Leyen, who had known close ties with Pfizer CEO. [1]

On June 18, 2022 the CDC’s vaccine advisory committee (ACIP) unanimously voted to advise the CDC to recommend all children—save for those who have contraindications to the vaccines—from 6 months through 5 years of age get the Moderna or Pfizer-BioNTech COVID-19 vaccines, both of which are built on the brand new messenger RNA (mRNA) technology. [1] Many watched the proceedings in horror of what they witnessed. 3000 out of 4536 children dropped out of the trial, and the vaccine group got more COVID-19 than the placebo group. American Academy of Pediatrics statement, "we've successfully immunised millions of children and adolescents against COVID-19. Families with infants and toddlers need and deserve the same chance to protect their children against this virus.  More than 30,000 children younder than 5 have been infected with COVID-19 [positive PCR result!] and more than 500 have died [is this with or from?]..." On June 17, 2022 the FDA granted EUA for Moderna and Pfizer-BioNTech for children 6 months to 5 and 4 years respectively, based on their advisory panels recommendation, even though there is no efficacy data. Australia's TGA will likely follow suit in a short time. Pfizer's shocking "twisted" data - WATCH Adverse Events in..> READ MORE

On May 20, 2021 Oxfam released a report titled, "COVID vaccines create 9 new billionaires with combined wealth greater than cost of vaccinating world's poorest countries". [3, 4] Topping the list are the CEOs of BioNTech and then Moderna.  The top 2 to 6 are linked to Moderna. Neither company had brought a product to market prior to their brand new technology COVID-19 mRNA vaccine. [1, 2] The last 3 billionaires are co-founders of CanSino Biologics, manufactures of China's Ad5-nCoV-S recombinant (Ad5-nCoV) vaccine against COVID-19. [3]

On 22 July 2021, the TGA grants provisional approval for Pfizer COVID-19 vaccine for use in 12 to 15 year olds. "The Therapeutic Goods Administration (TGA) has thoroughly, and independently, assessed the domestic and international evidence before extending its approval for the Pfizer vaccine to be administered to this age group." [1, 2] ATAGI was states as having "been meeting with global experts over recent days to inform their deliberations and expert advice," indicating that much or all of the data is coming from international regulator experience. At this time just under 15% of Australians had received 2 doses.

On December 19, 2020, Israel begins it's COVID-19 vaccine roll-out, the day after Hanukkah - "after paying a premium for supplies of the Pfizer/BioNTech vaccine"  The first shot began with Prime Minister Netanyahu. “If everyone cooperates, keeps the rules and goes to get vaccinated, we’ll get out of this and we could well be the first country in the world to emerge from this [pandemic]. Let’s do it together” said Netanyahu By January 1, 2021, more than 10% of Israel's population is said to have received their first dose of Pfizer's vaccine.  According to Pfizer executive Israel is ‘a sort of laboratory’ for Pfizer COVID vaccines. [1] Four days after roll out, "the more contagious U.K. variant [later called Alpha] was detected in four people, and by February 10, 2021 "while the vaccine is preventing illness in older people, the variant now makes up about 80 percent of new cases."